USPTO 2015–2025 USPTO PatentsView US Corporation

Accuray Incorporated

USPTO PatentsView assignee record - 121 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Accuray ranks #3,111 of 49,997 tracked US assignees by granted-patent volume, with 121 patents across 20 technology areas.

#3,111
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.6/100)
20.2
avg claims per patent
+79%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3111 · US Corporation #3,111 · 121 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 121 grants
  • TOP-DECILE #3,111/49,997
  • PHOTO-FINISH Bando Chemical…
  • CPC-FOCUS A61N · 20 areas
  • INNOV-PAR 52.6/100
  • CLAIMS-DENSE 20.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +79% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bando Chemical Industries, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Accuray

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Accuray's Innovation Score is 52.6/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Accuray's grants concentrate

Accuray Incorporated is a focused PatentsView assignee: 20 CPC subclasses with 91.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (22 grants) versus a trough of 4 in 2017. By volume, Accuray sits between Smartsky Networks LLC and Fuji Machine MFG. Co., Ltd..

Accuray's three-year grant acceleration

From 2019–2021 to 2022–2024, Accuray Incorporated moved from 38 to 46 grants (1.21x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #770. See the growth leaderboard.

Who files at Accuray's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Accuray holds 121 patents at rank #3,111, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Accuray

By rank, the assignees closest to #3,111 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Accuray's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Accuray, neither rank-band nor same-CPC leaders (those blocks stay above).

Accuray's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0510152025 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Accuray Incorporated patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 9 7.4%
2016 11 9.1%
2017 4 3.3%
2018 9 7.4%
2019 9 7.4%
2020 19 15.7%
2021 10 8.3%
2022 22 18.2%
2023 16 13.2%
2024 8 6.6%
2025partial year 4 3.3%

Where it ranks

Overall rank by patents

#3,111

of 49,997 tracked assignees

Innovation Score

52.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Accuray Incorporated's patent record in context - here's where to go next.

  • Accuray Incorporated's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 91.7% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #3,111 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Accuray Incorporated against Smartsky Networks LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.